A new report in JAMA Internal Medicine demonstrates how incorporating blood tests for HIV into standard COVID-19 screening in the emergency department allowed UChicago Medicine to maintain HIV screening volume during the pandemic.
Clinical practice guidelines for dealing with the physical and mental health of transgender people highlight the current lack of a solid research base which must be improved, according to a new study published in the journal BMJ Open.
Scientists at the Ragon Institute of MGH, MIT and Harvard discover that "elite controllers" have myeloid dendritic cells that display characteristics of trained innate immune cells.
From the very beginning of the AIDS epidemic in 1981, nurses have been at the forefront of patient care, advocacy, and research. But even in the age of antiretroviral therapy and pre-exposure prophylaxis, many challenges remain in reducing the impact of HIV and AIDS, according to the special May/June issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.
University of North Carolina at Chapel Hill and Duke University improve HIV care by gamifying it. Study shows users of mobile gaming app achieved viral suppression and better medication adherence.
New study presented at SCAI 2021 demonstrates HIV, mental health, obesity and substance use disorders as risk factors on most common type of heart disease in young Black patients
Researchers at Gladstone Institutes established a detailed atlas of the CD4+ T cells in individuals with HIV not on antiretroviral treatment, using a technology called CyTOF/PP-SLIDE, which they have honed over the years. The atlas is now published in the scientific journal Cell Reports.
Each year over 150,000 infants worldwide are infected with HIV in the womb, at birth, or through breastfeeding. Why transmission occurs in some cases but not others has long been a mystery, but now a team led by Weill Cornell Medicine and Duke University scientists has uncovered an important clue, with implications for how to eliminate infant HIV infections.
Cisgender sexual minority men and transgender women are aware of pre-exposure prophylaxis (PrEP), a daily pill for HIV-negative people to prevent HIV infection, but few are currently taking it, according to researchers at Rutgers. The study, published in the journal AIDS and Behavior, surveyed 202 young sexual minority men and transgender women - two high-priority populations for HIV prevention - to better understand why some were more likely than others to be taking PrEP.
With a focus on 30,688 people treated for HIV between 2003 and 2017 in seven Latin American countries, the study, published in The Lancet HIV, finds dramatic increases in life expectancy.